Scenarios that move TARA

Protara Therapeutics, Inc. - Common Stock

Scenarios that move TARA: 1 analysis, 0 positive, 1 negative.

1. 2026-10-15 · FDA expands ImmunityBio's Anktiva label for bladder cancer — ▼ · impact -32 · confidence low · horizon weeks

All scenarios · Run a scenario · Pricing